It is important to note that pancreatitis, medullary thyroid cancer, and multiple endocrine neoplasia syndrome type 2 (MEN2) are several contraindications for GLP-1 agonist use [17]. The gene discussed is GCG; the disease is medullary thyroid gland carcinoma.